Long-Term Satisfaction With Inflatable Penile Prosthesis Using the Satisfaction Survey for Inflatable Penile Implant in a Veteran Population.

IF 3.4 2区 医学 Q1 ANDROLOGY
Andrology Pub Date : 2026-09-04 DOI:10.1111/andr.70339
Anessa Sax-Bolder, Tad Manalo, Alan Makedon, Gary Shahinyan, Jeff Morrison, Rohan Bhalla, Mark D Sawyer, Granville L Lloyd
{"title":"Long-Term Satisfaction With Inflatable Penile Prosthesis Using the Satisfaction Survey for Inflatable Penile Implant in a Veteran Population.","authors":"Anessa Sax-Bolder, Tad Manalo, Alan Makedon, Gary Shahinyan, Jeff Morrison, Rohan Bhalla, Mark D Sawyer, Granville L Lloyd","doi":"10.1111/andr.70339","DOIUrl":null,"url":null,"abstract":"<p><p>Inflatable penile prosthesis (IPP) is the gold standard for refractory erectile dysfunction, yet long-term outcomes in the Veterans Affairs (VA) health care population remain incompletely characterized. Using the Satisfaction Survey for Inflatable Penile Implant (SSIPI)-a recently validated, English-language, IPP-specific instrument (16 items; 1-5 Likert scale; total score 16-80)-we conducted a retrospective chart review and telephone-administered survey as an Institutional Review Board-approved quality improvement project at our regional VA medical center. All men undergoing primary IPP implantation from 1993 to 2021 were identified. Of 114 patients (82 living, 32 deceased at census date), 52 of 82 living patients (63.4%) completed the SSIPI. Median follow-up was 129.4 months (IQR 46.9-203.0), and median age at first surgery was 62 years (IQR 58-67). Median total SSIPI score was 67.5/80 (IQR 58.0-76.0); 67.3% of respondents were satisfied or somewhat satisfied. Smokers reported significantly lower satisfaction with post-implant penile length than non-smokers (SSIPI item #8: median 3.0 vs. 4.5; Mann-Whitney U, p = 0.032), and 48.1% of all respondents scored ≤3 on this domain regardless of smoking status, highlighting the importance of preoperative counseling on length expectations. Patients with lower comorbidity burden (ASA ≤ 2) reported higher overall satisfaction than those with ASA ≥ 3 (mean 70.36 vs. 61.13; p = 0.028). Older age at surgery was positively correlated with overall satisfaction (Spearman ρ = 0.463, p < 0.001), supporting IPP as appropriate management in older patients. No significant differences in overall SSIPI score were observed by diabetes status or BMI. Long-term IPP satisfaction in this VA cohort was favorable overall. Smoking history and higher comorbidity burden identify patients warranting enhanced preoperative counseling. The SSIPI demonstrates utility as a long-term quality improvement outcome measure for IPP in a real-world VA setting.</p>","PeriodicalId":7898,"journal":{"name":"Andrology","volume":" ","pages":""},"PeriodicalIF":3.4000,"publicationDate":"2026-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Andrology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/andr.70339","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ANDROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Inflatable penile prosthesis (IPP) is the gold standard for refractory erectile dysfunction, yet long-term outcomes in the Veterans Affairs (VA) health care population remain incompletely characterized. Using the Satisfaction Survey for Inflatable Penile Implant (SSIPI)-a recently validated, English-language, IPP-specific instrument (16 items; 1-5 Likert scale; total score 16-80)-we conducted a retrospective chart review and telephone-administered survey as an Institutional Review Board-approved quality improvement project at our regional VA medical center. All men undergoing primary IPP implantation from 1993 to 2021 were identified. Of 114 patients (82 living, 32 deceased at census date), 52 of 82 living patients (63.4%) completed the SSIPI. Median follow-up was 129.4 months (IQR 46.9-203.0), and median age at first surgery was 62 years (IQR 58-67). Median total SSIPI score was 67.5/80 (IQR 58.0-76.0); 67.3% of respondents were satisfied or somewhat satisfied. Smokers reported significantly lower satisfaction with post-implant penile length than non-smokers (SSIPI item #8: median 3.0 vs. 4.5; Mann-Whitney U, p = 0.032), and 48.1% of all respondents scored ≤3 on this domain regardless of smoking status, highlighting the importance of preoperative counseling on length expectations. Patients with lower comorbidity burden (ASA ≤ 2) reported higher overall satisfaction than those with ASA ≥ 3 (mean 70.36 vs. 61.13; p = 0.028). Older age at surgery was positively correlated with overall satisfaction (Spearman ρ = 0.463, p < 0.001), supporting IPP as appropriate management in older patients. No significant differences in overall SSIPI score were observed by diabetes status or BMI. Long-term IPP satisfaction in this VA cohort was favorable overall. Smoking history and higher comorbidity burden identify patients warranting enhanced preoperative counseling. The SSIPI demonstrates utility as a long-term quality improvement outcome measure for IPP in a real-world VA setting.

退伍军人对充气阴茎假体的长期满意度调查。
充气阴茎假体(IPP)是治疗难治性勃起功能障碍的金标准,但退伍军人事务部(VA)医疗保健人群的长期结果仍不完全明确。使用充气阴茎植入物满意度调查(SSIPI)-最近经过验证的英语ipp专用仪器(16项;1-5李克特量表;总分16-80)-我们在我们的地区VA医疗中心进行了回顾性图表审查和电话管理调查,作为机构审查委员会批准的质量改进项目。从1993年到2021年,所有接受初次IPP植入的男性都被确定。114例患者(82例在世,32例死亡)中,82例在世患者中有52例(63.4%)完成了SSIPI。中位随访129.4个月(IQR 46.9 ~ 203.0),首次手术中位年龄为62岁(IQR 58 ~ 67)。sipi总分中位数为67.5/80 (IQR为58.0-76.0);67.3%的受访者表示满意或比较满意。吸烟者对阴茎植入后长度的满意度明显低于非吸烟者(SSIPI项目#8:中位数3.0 vs. 4.5; Mann-Whitney U, p = 0.032),无论吸烟状况如何,48.1%的受访者在这一领域得分≤3分,突出了术前咨询对阴茎长度预期的重要性。合并症负担较低(ASA≤2)的患者总体满意度高于ASA≥3的患者(平均70.36比61.13;p = 0.028)。手术年龄与总体满意度呈正相关(Spearman ρ = 0.463, p < 0.001),支持IPP作为老年患者的适当管理。糖尿病状态或BMI对总体ssii评分没有显著差异。该VA队列的长期IPP满意度总体上是有利的。吸烟史和较高的合并症负担确定患者需要加强术前咨询。在真实的VA环境中,SSIPI证明了IPP作为长期质量改进结果测量的效用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Andrology
Andrology ANDROLOGY-
CiteScore
9.10
自引率
6.70%
发文量
200
期刊介绍: Andrology is the study of the male reproductive system and other male gender related health issues. Andrology deals with basic and clinical aspects of the male reproductive system (gonads, endocrine and accessory organs) in all species, including the diagnosis and treatment of medical problems associated with sexual development, infertility, sexual dysfunction, sex hormone action and other urological problems. In medicine, Andrology as a specialty is a recent development, as it had previously been considered a subspecialty of urology or endocrinology
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书